Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$2.96
+1.72%
Mkt Cap $141.28M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
Implied Upside
+85.8%
Consensus $5.50 vs current $2.96
NASDAQ·Healthcare·Biotechnology
$2.96
+1.72%
Mkt Cap $141.28M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
+85.8%
Consensus $5.50 vs current $2.96